Search

everythinglearnresearchcommunity

for

Search:↓

Platelet-Rich Plasma (PRP) is a low-risk treatment for Androgenic Alopecia (AGA) that generally improves hair count or density, but more research is needed for optimization.

Hair density and thickness decrease in all scalp areas for East Asians with AGA.

Certain mutations in a hair growth-related gene cause a type of genetic hair loss.

Fibroblast growth factor receptor signaling controls cell development and repair, and its malfunction can cause disorders and cancer, but it also offers potential for targeted therapies.

Platelet-rich plasma might help with hair growth and skin conditions, but more research is needed to prove its effectiveness and safety.

Some breast cancer patients still experience hair loss three years after chemotherapy, especially with taxane-based treatments.

Adult mice can grow new hair from skin wounds.

Cells from a skin condition can create new hair follicles and similar growths in mice, and a specific treatment can reduce these effects.

Early onset hair loss linked to genetics and androgen levels.

Antiandrogens have important biological effects, but more research is needed to understand them fully and compare their effectiveness and side effects to other treatments.

Platelet-rich plasma treatment for non-scarring hair loss shows mixed results and needs more research.

The guide explains how to study human skin fat cells and their tissue, aiming to improve research and medical treatments.

A new gene variant in the DSP gene is linked to a unique type of hair loss.

Researchers found a new area on chromosome 2 linked to a genetic hair loss condition.

Certain genes on chromosomes 6, 10, 16, and 18 may increase the risk of alopecia areata.

FGF5 gene mutations cause unusually long eyelashes by affecting hair growth regulation.

A specific gene variant causes severe skin issues and increases infection risk, requiring careful medical monitoring.

The document concludes that injecting platelet-rich plasma can effectively treat androgenetic alopecia, a type of hair loss.

Platelet-rich plasma shows potential for hair loss and skin rejuvenation but needs more research for widespread use.

The lotion CG428 did not show effectiveness in treating permanent hair loss in breast cancer survivors.

Genes and epigenetic changes are important in the development of Polycystic Ovary Syndrome.

Metformin improves hair growth and menstrual frequency in women with PCOS and hirsutism.

Adenosine helps grow thicker hair in Japanese men with hair loss.

Dupilumab may help hair regrowth in some patients with severe atopic dermatitis, but results vary.

The conclusion is that PCOS is caused by ovarian sensitivity to hormones and disrupted hormone control, possibly due to ovarian factors, and more research is needed.

Genetic mutations can affect female sexual development, requiring personalized medical care.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

Dutasteride and finasteride do not significantly affect bone density, blood fats, or blood production, but slightly lower PSA levels and minimally impact sexual function in healthy young men.

Oxidative stress is a key factor in the development of Polycystic Ovary Syndrome, and weight management can improve symptoms.

A male with aromatase deficiency improved bone health with estradiol treatment.